Volume 29, Issue 155, January 2025

Intragastric Balloon vs. Endoscopic Sleeve Gastroplasty: A review of the efficacy and safety of both procedures

Hashim Mohamed Siraj¹, Aafreen Ali Nyaz^1♦, Ramlah Atif Khan¹, Mohammed Aamir Qayyum Sarguroh Khan¹, Sanaf Nisar Hamdulay¹, Nivedita Pant²

¹Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
²David Tvildiani Medical University, Tbilisi, Georgia

^♦Corresponding Author
Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia

ABSTRACT

The increasing prevalence of obesity worldwide has made it a global pandemic. In recent years, endoscopic bariatric therapies (EBTs), such as the intragastric balloon (IGB) and the endoscopic sleeve gastroplasty (ESG), have gained recognition for their effectiveness. This literature review compares IGB vs ESG, analyzing their relative efficacy in achieving weight loss and improving metabolic outcomes. It also assesses their safety profile parameters like procedure-related risks, adverse events, and long-term patient outcomes. Studies conducted between 2015 and 2022 that assessed parameters such as percentage total body weight loss (%TBWL) and body mass index (BMI) over a 12-month post-operative period were included in this review. The results indicate that while both procedures promote weight loss and enhance the patient’s quality of life, ESG is more effective in achieving sustainable weight loss and reducing comorbidities with low incidence of adverse events in comparison to intragastric balloons. The literature suggests that ESG is a comparatively safer and more effective alternative to IGBs for the treatment of obesity.

Keywords: Obesity, weight loss, Endoscopic Sleeve Gastroplasty, Intragastric Balloon.

Medical Science, 2025, 29, e19ms3513

PDF

DOI: https://doi.org/10.54905/disssi.v29i155.e19ms3513

Published: 27 January 2025